PARP inhibitors
29 Sep 2010
PARP inhibitors
The use of hormone therapy to treat advanced prostate cancer
The importance of a multi-disciplinary approach to the development of cancer treatments
Cross border healthcare: a necessity for cancer patients
Defining molecular profiles on circulating tumour cells
Breast imaging with MRI: how to use?
Androgen receptors: prognostic and therapeutic relevance
The impact of lifestyle on breast cancer risk
High-risk genes for breast cancer: the genetic 'Foucault pendulum'
Update of the NSABP STAR trial: preventing breast cancer
New endocrine agents for prevention of breast cancer
Spotlight on circulating tumour cells